Searched for
HISTORY OF INDIAN PHARMA
India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Midcap, smallcap rally has eroded margin of safety, rotate to largecaps: Axis Direct's Rajesh PalviyaAxis Direct suggests a selective shift towards large-cap stocks now. Mid and small caps show stretched valuations after their recent surge....
- AI is reshaping hiring, making evidence-based verification more critical: Millow's Karan BhattyAI is revolutionising Indian hiring by enhancing candidate preparation and employer verification processes. Companies now prioritise eviden...
- F&O Talk: Nifty IT gaining strong momentum, says Sudeep Shah; outlines HDFC Bank, ICICI Bank strategy after Q1The Nifty IT index has rebounded nearly 13.5% from its July 1 low and gained around 5% this week, signalling improving momentum. Technical ...
- For investors with high risk-appetite: 5 mid-cap stocks from different sectors with upside potential of up to 21%Brace for trouble. The US-Iran conflict now appears to be gaining in intensity and the commodities market is taking the current spiral of v...
- If FIIs return, they tend to see it first. 15 stocks from financial services ecosystem, with upside potential as low as 3% to as high as 28%Financial services is where FIIs go when they turn positive on India. History shows us that much of the money goes to banks, and the wider ...
- Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- US envoy to India meets Trump, discusses 'strong future of India-US ties'US Ambassador to India, Sergio Gor, attended a White House dinner with President Trump, discussing US-India ties and global stability. Gor ...
- What spooked Sun Pharma stock in Monday’s tradeA total of 93 per cent of revenue of Sun Pharma’s US unit comes from US operations.
- New legal risks emerge for Indian pharmaDr Reddy’s Labs, Aurobindo, Cadila and Glenmark face the highest risk
- Indian execs 'named' in US pharma caseThe Indian generic makers named in the lawsuit are Aurobindo, Dr Reddy’s, Emcure, Glenmark, and Zydus.
- Torrent Pharma completes acquisition of Unichem Laboratories Ltdhe acquisition will accelerate Torrent's presence in the chronic space especially in the high growth segments of Indian Pharma market like ...
- India Inc creates oral history to preserve legacyGodrej Group and Cipla, for instance, are making attempts to preserve their legacy and of their iconic products which transformed the lives...
- Low diagnostics rate, Nutrition are the focus areas: Abbott IndiaIndia’s low rate of diagnosis and disease awareness present ample opportunity for drugmakers to do more in the country
- New definition of counterfeit worries drug cos, NGOsThe Indian drug industry and public health interest groups have voiced strong concerns over the new definition of counterfeit drugs that ha...
Load More
